메뉴 건너뛰기




Volumn 40, Issue 1, 2012, Pages 4-6

Chronic cough and sputum production: A clinical COPD phenotype?

Author keywords

[No Author keywords available]

Indexed keywords

MOXIFLOXACIN; ROFLUMILAST;

EID: 84863471264     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00022412     Document Type: Editorial
Times cited : (31)

References (27)
  • 2
    • 79551603829 scopus 로고    scopus 로고
    • Characterisation of COPD heterogeneity in the ECLIPSE cohort
    • Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122.
    • (2010) Respir Res , vol.11 , pp. 122
    • Agusti, A.1    Calverley, P.M.2    Celli, B.3
  • 3
    • 80053534329 scopus 로고    scopus 로고
    • Avoiding confusion in COPD: From risk factors to phenotypes to measures of disease characterisation
    • Agusti A, Celli B. Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. Eur Respir J 2011; 38: 749-751.
    • (2011) Eur Respir J , vol.38 , pp. 749-751
    • Agusti, A.1    Celli, B.2
  • 4
    • 77957705828 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease phenotypes: The future of COPD
    • Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182: 598-604.
    • (2010) Am J Respir Crit Care Med , vol.182 , pp. 598-604
    • Han, M.K.1    Agusti, A.2    Calverley, P.M.3
  • 5
    • 2442571198 scopus 로고    scopus 로고
    • The British hypothesis revisited
    • Anthonisen NR. The British hypothesis revisited. Eur Respir J 2004; 23: 657-658.
    • (2004) Eur Respir J , vol.23 , pp. 657-658
    • Anthonisen, N.R.1
  • 6
    • 0017402583 scopus 로고
    • The natural history of chronic airflow obstruction
    • Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
    • (1977) BMJ , vol.1 , pp. 1645-1648
    • Fletcher, C.1    Peto, R.2
  • 7
    • 0029947193 scopus 로고    scopus 로고
    • Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity
    • Copenhagen City Heart Study Group
    • Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153: 1530-1535.
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 1530-1535
    • Vestbo, J.1    Prescott, E.2    Lange, P.3
  • 8
    • 0035422691 scopus 로고    scopus 로고
    • Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: Results from the lung health study
    • Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001; 164: 358-364.
    • (2001) Am J Respir Crit Care Med , vol.164 , pp. 358-364
    • Kanner, R.E.1    Anthonisen, N.R.2    Connett, J.E.3
  • 9
    • 26244444367 scopus 로고    scopus 로고
    • Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis
    • Ekberg-Aronsson M, Pehrsson K, Nilsson JA, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98-107.
    • (2005) Respir Res , vol.6 , pp. 98-107
    • Ekberg-Aronsson, M.1    Pehrsson, K.2    Nilsson, J.A.3
  • 10
    • 0025033561 scopus 로고
    • Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes
    • Lange P, Nyboe J, Appleyard M, et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45: 579-585.
    • (1990) Thorax , vol.45 , pp. 579-585
    • Lange, P.1    Nyboe, J.2    Appleyard, M.3
  • 11
    • 33750048426 scopus 로고    scopus 로고
    • Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: A follow-up in middleaged rural men
    • Pelkonen M, Notkola IL, Nissinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middleaged rural men. Chest 2006; 130: 1129-1137.
    • (2006) Chest , vol.130 , pp. 1129-1137
    • Pelkonen, M.1    Notkola, I.L.2    Nissinen, A.3
  • 12
    • 0033781008 scopus 로고    scopus 로고
    • Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: A multiple logistic regression analysis
    • Miravitlles M, Guerrero T, Mayordomo C, et al. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration 2000; 67: 495-501.
    • (2000) Respiration , vol.67 , pp. 495-501
    • Miravitlles, M.1    Guerrero, T.2    Mayordomo, C.3
  • 13
    • 0031746535 scopus 로고    scopus 로고
    • Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
    • Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
    • (1998) Am J Respir Crit Care Med , vol.157 , pp. 1418-1422
    • Seemungal, T.A.1    Donaldson, G.C.2    Paul, E.A.3
  • 14
    • 84862491658 scopus 로고    scopus 로고
    • The chronic bronchitis phenotype in subjects with and without COPD: The PLATINO study
    • Montes de Oca M, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J 2012; 40: 28-36.
    • (2012) Eur Respir J , vol.40 , pp. 28-36
    • Montes De Oca, M.1    Halbert, R.J.2    Lopez, M.V.3
  • 15
    • 64749104557 scopus 로고    scopus 로고
    • Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects
    • Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009; 135: 975-982.
    • (2009) Chest , vol.135 , pp. 975-982
    • Burgel, P.R.1    Nesme-Meyer, P.2    Chanez, P.3
  • 16
    • 80052690031 scopus 로고    scopus 로고
    • The chronic bronchitic phenotype of COPD: An analysis of the COPDGene study
    • Kim V, Han MLK, Vance GB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene study. Chest 2011; 140: 626-633.
    • (2011) Chest , vol.140 , pp. 626-633
    • Kim, V.1    Han, M.L.K.2    Vance, G.B.3
  • 17
    • 77957278202 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China
    • Lu M, Yao WZ, Zhong NS, et al. Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China. Respirology 2010; 15: 1072-1078.
    • (2010) Respirology , vol.15 , pp. 1072-1078
    • Lu, M.1    Yao, W.Z.2    Zhong, N.S.3
  • 18
    • 0029150812 scopus 로고
    • Chronic mucus hypersecretion in COPD and death from pulmonary infection
    • Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995; 8: 1333-1338.
    • (1995) Eur Respir J , vol.8 , pp. 1333-1338
    • Prescott, E.1    Lange, P.2    Vestbo, J.3
  • 19
    • 0036682945 scopus 로고    scopus 로고
    • Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?
    • Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002; 166: 329-332.
    • (2002) Am J Respir Crit Care Med , vol.166 , pp. 329-332
    • Vestbo, J.1    Lange, P.2
  • 20
    • 77956689733 scopus 로고    scopus 로고
    • Susceptibility to exacerbation in chronic obstructive pulmonary disease
    • Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
    • (2010) N Engl J Med , vol.363 , pp. 1128-1138
    • Hurst, J.R.1    Vestbo, J.2    Anzueto, A.3
  • 21
    • 34447310046 scopus 로고    scopus 로고
    • Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease
    • Calverley PMA, Sanchez-Torill F, McIvor A, et al. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 154-161.
    • (2007) Am J Respir Crit Care Med , vol.176 , pp. 154-161
    • Calverley, P.M.A.1    Sanchez-Torill, F.2    McIvor, A.3
  • 22
    • 79251588730 scopus 로고    scopus 로고
    • Reduction of exacerbations by the PDE4 inhibitor roflumilast - The importance of defining different subsets of patients with COPD
    • Rennard SI, Calverley PMA, Goehring UM, et al. Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD. Respir Res 2011; 12: 18.
    • (2011) Respir Res , vol.12 , pp. 18
    • Rennard, S.I.1    Calverley, P.M.A.2    Goehring, U.M.3
  • 23
    • 77952490797 scopus 로고    scopus 로고
    • Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial
    • Sethi S, Jones PW, Theron MS, et al. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res 2010; 11: 10.
    • (2010) Respir Res , vol.11 , pp. 10
    • Sethi, S.1    Jones, P.W.2    Theron, M.S.3
  • 24
    • 69149103642 scopus 로고    scopus 로고
    • Roflumilast in symptomatic chronic obstructive pulmonary disease: Two randomised clinical trials
    • Calverley PM, Rabe KF, Goehring UM, et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009; 374: 685-694.
    • (2009) Lancet , vol.374 , pp. 685-694
    • Calverley, P.M.1    Rabe, K.F.2    Goehring, U.M.3
  • 25
    • 79959362446 scopus 로고    scopus 로고
    • Complex systems in pulmonary medicine: A systems biology approach to lung disease
    • Kaminsky DA, Irvin CG, Sterk PJ. Complex systems in pulmonary medicine: a systems biology approach to lung disease. J Appl Physiol 2011; 110: 1716-1722.
    • (2011) J Appl Physiol , vol.110 , pp. 1716-1722
    • Kaminsky, D.A.1    Irvin, C.G.2    Sterk, P.J.3
  • 26
    • 77953389042 scopus 로고    scopus 로고
    • Clinical COPD phenotypes: A novel approach using principal component and cluster analyses
    • Burgel PR, Paillasseur JL, Caillaud D, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010; 36: 531-539.
    • (2010) Eur Respir J , vol.36 , pp. 531-539
    • Burgel, P.R.1    Paillasseur, J.L.2    Caillaud, D.3
  • 27
    • 69249098135 scopus 로고    scopus 로고
    • Distinct clinical phenotypes of airways disease defined by cluster analysis
    • Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009; 34: 812-818.
    • (2009) Eur Respir J , vol.34 , pp. 812-818
    • Weatherall, M.1    Travers, J.2    Shirtcliffe, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.